ADHD - Combined Type Clinical Trial
Official title:
Multimodal Brain Imaging of the Neural Effects of Methylphenidate in Patients With ADHD
The investigators' goal is to develop neuroimaging biomarkers to predict response to treatment with methylphenidate, which then can be used in the development of novel pharmacological treatments for attention-deficit/hyperactivity disorder (ADHD). The overall objective of this study is to measure the changes in task-related neural activity related to symptoms of ADHD (measured by functional MRI) and brain glutamate levels (measured by magnetic resonance spectroscopy, MRS) after treatment with methylphenidate (MPH). This will be a double-blind crossover of methylphenidate and placebo in adults with ADHD. Participants will complete neuropsychological testing along with fMRI and MRS scans after a single dose of each treatment.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT06081348 -
Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders
|
Phase 2 | |
| Completed |
NCT04799886 -
Attitudes Associated to Prescription of ADHD Drugs Among Child and Adolescent Psychiatrists in Region Skåne.
|
||
| Completed |
NCT04511169 -
MyADHD-digital Training for Adults With ADHD
|
N/A | |
| Completed |
NCT05452954 -
Psychosocial ADHD Interventions - Brief Parent Training
|
N/A | |
| Recruiting |
NCT03313349 -
A School-Based Intervention to Improve Social Functioning
|
N/A | |
| Completed |
NCT01727414 -
Attention Deficit Disorder Medication Response Study
|
Phase 4 | |
| Active, not recruiting |
NCT05930912 -
Psychiatric Orders in Psychoanalytic Treatment of ASD
|
||
| Recruiting |
NCT05924594 -
Phase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301
|
Phase 3 | |
| Active, not recruiting |
NCT05286762 -
Phase 3 Efficacy and Safety Fixed-Dose Study in Pediatrics (6-17) With ADHD Using CTx-1301
|
Phase 3 | |
| Not yet recruiting |
NCT06235177 -
Psychoneuromentalism Disorder: A Medical Condition That Affects People With Psychological Impairments From Health Issues
|
Early Phase 1 | |
| Recruiting |
NCT04504890 -
Ocular-vestibular Biomarker Identification for ADHD
|
||
| Recruiting |
NCT06299189 -
A Therapist Guided Internet-delivered Treatment for Adults With ADHD (Attention Deficit / Hyperactivity Disorder) - an Open Effectiveness Trial in Routine Care
|
N/A | |
| Recruiting |
NCT04729439 -
Technology-Enhanced Executive Functioning Intervention for ADHD
|
Phase 1 | |
| Completed |
NCT03335748 -
the Cogmed Program for Youths With ADHD
|
N/A | |
| Completed |
NCT05631626 -
Phase 3 Efficacy and Safety Study in Adults With ADHD Using CTx-1301.
|
Phase 3 |